Novel therapeutic strategies for reducing arterial stiffness.
作者信息
McEniery Carmel M
机构信息
Clinical Pharmacology Unit, University of Cambridge, Addenbrooke's Hospital, Cambridge CB2 2QQ.
出版信息
Br J Pharmacol. 2006 Aug;148(7):881-3. doi: 10.1038/sj.bjp.0706805. Epub 2006 Jun 19.
Abstract
摘要
相似文献
1
Novel therapeutic strategies for reducing arterial stiffness.
Br J Pharmacol. 2006 Aug;148(7):881-3. doi: 10.1038/sj.bjp.0706805. Epub 2006 Jun 19.
2
Advanced glycation end-products as a potential target for treatment of cardiovascular disease.
J Hypertens. 2002 Aug;20(8):1483-5. doi: 10.1097/00004872-200208000-00007.
3
Crosslink breakers: a new approach to cardiovascular therapy.
Curr Opin Cardiol. 2004 Jul;19(4):336-40. doi: 10.1097/01.hco.0000127135.73849.4f.
4
Clinical applications of arterial stiffness: therapeutics and pharmacology.
Am J Hypertens. 2002 May;15(5):453-8. doi: 10.1016/s0895-7061(01)02329-9.
5
Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.
Reprod Sci. 2015 Jul;22(7):774-82. doi: 10.1177/1933719114549845. Epub 2014 Sep 16.
6
Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease.
Congest Heart Fail. 2004 May-Jun;10(3):144-9; quiz 150-1. doi: 10.1111/j.1527-5299.2004.03223.x.
7
Aortic wave velocity: a noninvasive method to measure the stiffness of arteries and the clinical results of supplements that appear to improve arterial stiffness.
Curr Aging Sci. 2013 Feb;6(1):76-85. doi: 10.2174/1874609811306010010.
8
Age, hypertension and arterial function.
Clin Exp Pharmacol Physiol. 2007 Jul;34(7):665-71. doi: 10.1111/j.1440-1681.2007.04657.x.
9
Inhibition of renin-angiotensin system and advanced glycation end products formation: a promising therapeutic approach targeting on cardiovascular diseases.
Cardiovasc Hematol Agents Med Chem. 2007 Oct;5(4):249-64. doi: 10.2174/187152507782109926.
10
Therapeutic Interventions for Advanced Glycation-End Products and its Receptor- Mediated Cardiovascular Disease.
Curr Pharm Des. 2017;23(6):937-943. doi: 10.2174/1381612822666161006143032.
引用本文的文献
1
Acute effects of commercial group exercise classes on arterial stiffness and cardiovagal modulation in healthy young and middle-aged adults: A crossover randomized trial.
PLoS One. 2025 Mar 13;20(3):e0319130. doi: 10.1371/journal.pone.0319130. eCollection 2025.
2
Pyridoxamine treatment ameliorates large artery stiffening and cerebral artery endothelial dysfunction in old mice.
J Cereb Blood Flow Metab. 2023 Feb;43(2):281-295. doi: 10.1177/0271678X221130124. Epub 2022 Oct 2.
3
Arterial stiffness and the response to carotid sinus massage in older adults.
Aging Clin Exp Res. 2010 Feb;22(1):36-41. doi: 10.3275/6810. Epub 2010 Feb 5.
4
Short-term aerobic exercise reduces arterial stiffness in older adults with type 2 diabetes, hypertension, and hypercholesterolemia.
Diabetes Care. 2009 Aug;32(8):1531-5. doi: 10.2337/dc09-0149. Epub 2009 Jun 9.
本文引用的文献
1
Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats.
Br J Pharmacol. 2006 Aug;148(7):902-8. doi: 10.1038/sj.bjp.0706801. Epub 2006 Jun 19.
2
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study.
Circulation. 2006 Mar 7;113(9):1213-25. doi: 10.1161/CIRCULATIONAHA.105.595496. Epub 2006 Feb 13.
3
Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT).
J Am Coll Cardiol. 2005 Nov 1;46(9):1753-60. doi: 10.1016/j.jacc.2005.07.037. Epub 2005 Oct 10.
4
Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults.
Circulation. 2005 Jun 28;111(25):3384-90. doi: 10.1161/CIRCULATIONAHA.104.483628. Epub 2005 Jun 20.
5
Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?
Circulation. 2002 Oct 15;106(16):2085-90. doi: 10.1161/01.cir.0000033824.02722.f7.
6
Inhibitor for advanced glycation end products formation attenuates hypertension and oxidative damage in genetic hypertensive rats.
J Hypertens. 2002 Aug;20(8):1607-14. doi: 10.1097/00004872-200208000-00024.
7
Central pulse pressure and mortality in end-stage renal disease.
Hypertension. 2002 Mar 1;39(3):735-8. doi: 10.1161/hy0202.098325.
8
Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age.
Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2046-50. doi: 10.1161/hq1201.100226.
9
Aminoguanidine and aortic wall mechanics, structure, and composition in aged rats.
Hypertension. 2001 Oct;38(4):943-8. doi: 10.1161/hy1001.096211.
10
Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.
Circulation. 2001 Sep 25;104(13):1464-70. doi: 10.1161/hc3801.097806.
Zotero 插件